The Human Factor: The Cost of Switching from Analog to Human Insulin.
作者信息
Tsai Allison
出版信息
Diabetes Forecast. 2017 Mar;70(2):44-47.
PMID:29897684
Abstract
摘要
相似文献
1
The Human Factor: The Cost of Switching from Analog to Human Insulin.
Diabetes Forecast. 2017 Mar;70(2):44-47.
2
Evidence to Avoid Overtesting and Overuse in Diabetes Mellitus and Other Diseases.
Am Fam Physician. 2020 Nov 15;102(10):583-584.
3
Effect of a Virtual Pharmacy Review Program: A Population Health Case Study.
J Manag Care Spec Pharm. 2020 Jan;26(1):24-29. doi: 10.18553/jmcp.2020.26.1.24.
4
Liraglutide vs. sitagliptin add-on to metformin treatment for type 2 diabetes mellitus: Short-term cost-per-controlled patient in Italy.
Prim Care Diabetes. 2016 Jun;10(3):220-6. doi: 10.1016/j.pcd.2015.10.002. Epub 2015 Nov 3.
5
Diabetes News.
J Diabetes. 2015 Nov;7(6):749-53. doi: 10.1111/1753-0407.12328.
6
Insulin Access and Affordability Working Group: Conclusions and Recommendations.
Diabetes Care. 2018 Jun;41(6):1299-1311. doi: 10.2337/dci18-0019. Epub 2018 May 8.
7
A New Algorithm Dedicated to Blood Glucose Monitoring in Insulin-Treated Elderly Dependent People With Diabetes.
J Diabetes Sci Technol. 2019 Mar;13(2):410-412. doi: 10.1177/1932296818815453. Epub 2018 Dec 12.
8
Impact of a reduced error range of SMBG in insulin-treated patients in Germany.
J Diabetes Sci Technol. 2014 May;8(3):479-82. doi: 10.1177/1932296813516206. Epub 2014 Feb 5.
9
Biosimilar Insulin and Costs: What Can We Expect?
J Diabetes Sci Technol. 2015 Sep 8;10(2):457-62. doi: 10.1177/1932296815605337.
10
HONE IN ON THE RANGE.
Diabetes Self Manag. 2015 Jul-Aug;32(4):18-20, 23.
Zotero 插件